Yimmugo (immune globulin intravenous, human - dira)
(immune globulin intravenous, human - dira)Biotest AG
Usage: YIMMUGO is indicated for treating primary humoral immunodeficiency (PI) in patients aged 2 and older, including conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia (XLA), Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).